• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women

tetano

Editor, Senior Moderator
AIDS Res Hum Retroviruses. 2015 Aug 31. [Epub ahead of print]
[h=1]Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women.[/h] Weinberg A[SUP]1[/SUP], Muresan P[SUP]2[/SUP], Richardson K[SUP]1[/SUP], Fenton T[SUP]2[/SUP], Dominguez T[SUP]1[/SUP], Bloom A[SUP]3[/SUP], Watts DH[SUP]4[/SUP], Abzug MJ[SUP]1[/SUP], Nachman SA[SUP]5[/SUP], Levin MJ[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] We investigated the Th1 protective and regulatory T and B cell (Treg and Breg) responses to pH1N1 monovalent influenza vaccine (IIV1) in HIV-infected pregnant women on combination antiretroviral therapy (cART). Peripheral blood mononuclear cells (PBMCs) from 52 study participants were cryopreserved before and after vaccination and analyzed by flow cytometry. pH1N1-specific Th1, Treg, and Breg responses were measured in PBMCs after in vitro stimulation with pH1N1 and control antigen. The cohort analysis did not detect changes in pH1N1-Th1, Treg, or Breg subsets postvaccination. However, individual analyses distinguished subjects who mounted vigorous Th1 responses postvaccination from others who did not. Postvaccination, high pH1N1-Th1 correlated with high pH1N1-Treg and Breg responses, suggesting that low influenza effector responses did not result from excessive vaccine-induced immune regulation. High postvaccination pH1N1-Th1 responses correlated with baseline high PHA- and pH1N1-IFN-γ ELISpot and circulating CD4[SUP]+[/SUP]CD39[SUP]+[/SUP]% and CD8[SUP]+[/SUP]CD39[SUP]+[/SUP]% Treg, with low CD8[SUP]+[/SUP] cell numbers and CD19[SUP]+[/SUP]FOXP3[SUP]+[/SUP]% Breg, but not with CD4[SUP]+[/SUP] cell numbers or HIV viral load. These data highlight the heterogeneity of T cell responses to vaccines in HIV-infected individuals on cART. Predictors of robust Th1 responses to IIV include CD8[SUP]+[/SUP] cell numbers, T cell functionality, and circulating Breg and Treg.


PMID: 26322930 [PubMed - as supplied by publisher]
 
Back
Top Bottom